Innate Pharma Files 6-K Report
Ticker: IPHYF · Form: 6-K · Filed: May 19, 2025 · CIK: 1598599
| Field | Detail |
|---|---|
| Company | Innate Pharma SA (IPHYF) |
| Form Type | 6-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, foreign-private-issuer, press-release
TL;DR
Innate Pharma dropped a 6-K on 5/19, likely with news.
AI Summary
On May 19, 2025, Innate Pharma SA filed a Form 6-K, reporting a press release dated May 19, 2025. The company, based in Marseille, France, is a biopharmaceutical company focused on biological products.
Why It Matters
This filing indicates Innate Pharma is providing updated information to the SEC, which could include significant business developments or financial updates relevant to investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a press release and does not inherently contain negative or positive financial news.
Key Players & Entities
- Innate Pharma SA (company) — Registrant
- May 19, 2025 (date) — Filing Date and Press Release Date
- Marseille, France (location) — Company Headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public pursuant to the laws of their home country, or that they have filed or are required to file with a stock exchange.
What is the primary business of Innate Pharma SA?
Innate Pharma SA is primarily involved in the business of biological products, specifically excluding diagnostic substances, as indicated by its SIC code 2836.
When was the press release mentioned in the filing dated?
The press release mentioned in the filing is dated May 19, 2025.
What is the SEC file number for Innate Pharma SA?
The SEC file number for Innate Pharma SA is 001-39084.
Does Innate Pharma SA file annual reports under Form 20-F or 40-F?
Innate Pharma SA indicates that it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 19, 2025 regarding Innate Pharma SA (IPHYF).